Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Multi-Dose, Open-Label Maintenance of Long-Term Safety and Efficacy of Sodium Zirconium Cyclosilicate (ZS) in Hyperkalemia

NCT02163499 is registered in ClinicalTrials.gov with ZS Pharma, Inc. as lead sponsor.

NCT NCT02163499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02163499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Multi-Dose, Open-Label Maintenance of Long-Term Safety and Efficacy of Sodium Zirconium Cyclosilicate (ZS) in Hyperkalemia
Lead sponsor
ZS Pharma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2014
Completion date
November 30, 2016
Enrollment
751 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia